Mortensen J T, Olsen J, Larsen H, Bendsen J, Obel C, Sørensen H T
Department of Clinical Epidemiology, Aarhus University and Aalborg Hospitals, Stengade 10, Box 561, Aalborg, Denmark.
Eur J Epidemiol. 2003;18(8):769-71. doi: 10.1023/a:1025306304635.
We did a follow-up study based upon a regional prescription register in Denmark. We identified all 435 women who in the period 1991-1996 had redeemed a prescription for CNS drugs during pregnancy. Among the rest of the pregnant women we randomly selected 1304 women who also had given birth to a child in the same region and period. We looked up the local health nurses Boel test results which were available for about 80%. Any abnormal test result was seen much more frequently among exposed (16%) than for not exposed (4%). The study has several limitations but raises concern that should be addressed in other and better designed studies.
我们基于丹麦的一个地区处方登记系统进行了一项随访研究。我们确定了在1991年至1996年期间怀孕期间兑换过中枢神经系统药物处方的所有435名女性。在其余的孕妇中,我们随机选择了1304名同样在同一地区和时期分娩的女性。我们查阅了当地健康护士约80%可获取的伯尔测试结果。暴露组(16%)出现任何异常测试结果的频率远高于未暴露组(4%)。该研究有几个局限性,但引发了一些担忧,这些担忧应在其他设计更好的研究中加以解决。